Translational Geroscience Strategies For Delaying Multimorbidity
As our global population ages, a significant challenge arises from the increasing prevalence of “multimorbidity”—the co-occurrence of multiple chronic diseases in one individual. Traditionally, medicine has focused on treating these diseases one by one. However, a new approach called “geroscience” is gaining traction, proposing that we can tackle multimorbidity by addressing the root causes of aging itself. This field views aging not as an unchangeable fate, but as a modifiable risk factor for disease.
The core idea is that by slowing down the biological processes that drive aging, we can delay or even prevent a whole host of age-related conditions at once. Imagine extending your “healthspan”—the period of life free from serious chronic diseases and disability—rather than just your lifespan.
Researchers are exploring exciting interventions. One promising area is “senolytics,” which are compounds designed to selectively eliminate “senescent cells.” These are old, damaged cells that accumulate in the body as we age and contribute to inflammation and tissue dysfunction. Another strategy involves “epigenetic reprogramming,” which aims to reverse age-related changes in how our genes are expressed without altering the underlying DNA sequence.
While these strategies hold immense promise, there are challenges to overcome, such as ensuring interventions are effective across different individuals and addressing safety concerns. The future of this field involves developing personalized approaches, leveraging advanced tools like artificial intelligence for drug discovery, and integrating various biological data to create a comprehensive roadmap for healthier aging. The ultimate goal is to shift the medical paradigm towards promoting a life balanced with resilience and vitality, rather than simply managing decline.
Source: link to paper